Who invested in Celladon

12 rounds we have observed, with the 18 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$172Mraised across 12 rounds since 2005, from 12 sources

$30MSeries B$22MSeries C$3.5MDebt$2.5MDebt$400KDebt$250KDebt$500KDebt$43MVenture$19MVenture$10MVenture$1.1MDebt$40MRound

Latest round: Round, $40MNov 2015
Biggest round: $43MVenture · Feb 2012
Step-upi: 36×
Investors: 18

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20072009201120132015

$30MSeries B$22MSeries C$3.5MDebt$2.5MDebt$400KDebt$500KDebt$1.1MDebt$40MRound

First round: Series B, $30M
Biggest round: $43M
Usual gap between rounds: 9 months

The rounds

Nov 2015
Round$40M8 new
- RA Capital Management
- InterWest Partners
- Perceptive Advisors
- Vivo Capital
- Sabby Capital
- HBM Healthcare Investments AG
- Monashee Capital Partners
- Sphera Global Healthcare Fund
From a historical funding record
Oct 2013
Debt$1.1M
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Oct 2013
May 2012
Venture$19M
No investor was named in the report.
Reported by sec.govSEC filing: $19M sold, first sale Jan 2012
May 2012
Venture$10M1 new
- MPM Capital
Reported by finsmes.comSEC filing: $19M sold, first sale Jan 2012
Feb 2012
Venture$43M4 new2 returning
Reported by finsmes.comSEC filing: $18M sold, first sale Jan 2012
Dec 2011
Debt$500K
No investor was named in the report.
Reported by sec.govSEC filing: $500K sold, first sale Dec 2011
Sept 2011
Debt$250K
No investor was named in the report.
Reported by sec.govSEC filing: $250K sold, first sale Aug 2011
Jul 2011
Debt$400K
No investor was named in the report.
Reported by sec.govSEC filing: $400K sold, first sale Jun 2011
Oct 2010
Debt$2.5M
No investor was named in the report.
From a historical funding recordSEC filing: $2.5M sold, first sale Aug 2010
Dec 2009
Debt$3.5M
No investor was named in the report.
From a historical funding recordSEC filing: $3.5M sold, first sale Dec 2009
Nov 2009
Series C$22M1 new2 returning
Reported by onbiovc.comSEC filing: $3.5M sold, first sale Dec 2009
Dec 2005
Series B$30M4 new
Reported by thefreelibrary.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2011Debt2011Debt2011Venture2012Venture2012Venture2012Debt2013Round2015

Venrock

Johnson & Johnson Development Corporation (JJDC)

Enterprise Partners Venture Capital

Kleiner Perkins Caufield & Byers

RA Capital Management

InterWest Partners

Perceptive Advisors

Domain Associates

Novartis Venture Fund

Vivo Capital

Everyone who backed them

VenrockVC firm3rounds

Johnson & Johnson Development Corporation (JJDC)VC firm2rounds

Enterprise Partners Venture CapitalVC firm2rounds

Kleiner Perkins Caufield & ByersVC firm1round

RA Capital ManagementPrivate equity1round

InterWest PartnersVC firm1round

Perceptive AdvisorsAsset manager1round

Domain AssociatesVC firm1round

Novartis Venture FundCorporate VC1round

Vivo CapitalPrivate equity1round

MPM CapitalPrivate equity1round

PfizerCorporate VC1round

GBS VenturesVC firm1round

Lundbeckfond VenturesVC firm1round

Sabby CapitalPrivate equity1round

HBM Healthcare Investments AGPrivate equity1round

Monashee Capital Partnersno record of our own yet1round

Sphera Global Healthcare Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Celladon

Who invested in Celladon?

Celladon's investors include Venrock, Johnson & Johnson Development Corporation (JJDC), Enterprise Partners Venture Capital, Kleiner Perkins Caufield & Byers and RA Capital Management, and 13 more on record.